Correlation Between Appili Therapeutics and Melcor Developments

Can any of the company-specific risk be diversified away by investing in both Appili Therapeutics and Melcor Developments at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Appili Therapeutics and Melcor Developments into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Appili Therapeutics and Melcor Developments, you can compare the effects of market volatilities on Appili Therapeutics and Melcor Developments and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Appili Therapeutics with a short position of Melcor Developments. Check out your portfolio center. Please also check ongoing floating volatility patterns of Appili Therapeutics and Melcor Developments.

Diversification Opportunities for Appili Therapeutics and Melcor Developments

-0.89

Correlation Coefficient

Appili Therapeutics  Melcor Developments

Pay attention - limited upside

The 3 months correlation between Appili and Melcor is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding Appili Therapeutics and Melcor Developments in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Melcor Developments and Appili Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Appili Therapeutics are associated (or correlated) with Melcor Developments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Melcor Developments has no effect on the direction of Appili Therapeutics i.e., Appili Therapeutics and Melcor Developments go up and down completely randomly.

Pair Corralation between Appili Therapeutics and Melcor Developments

Assuming the 90 days trading horizon Appili Therapeutics is expected to under-perform the Melcor Developments. In addition to that, Appili Therapeutics is 8.19 times more volatile than Melcor Developments. It trades about -0.02 of its total potential returns per unit of risk. Melcor Developments is currently generating about 0.19 per unit of volatility. If you would invest  1,178  in Melcor Developments on April 20, 2025 and sell it today you would earn a total of  236.00  from holding Melcor Developments or generate 20.03% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Appili Therapeutics  vs.  Melcor Developments

Appili Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Appili Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in August 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Melcor Developments

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Melcor Developments are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Melcor Developments displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Appili Therapeutics and Melcor Developments

The main advantage of trading using opposite Appili Therapeutics and Melcor Developments positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Appili Therapeutics position performs unexpectedly, Melcor Developments can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Melcor Developments will offset losses from the drop in Melcor Developments' long position.

The idea behind Appili Therapeutics and Melcor Developments pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.